Holen Sie sich die Stockscreener-App
21.53
2.23%
0.50
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Midday Stock Roundup: EnVVeno down 15% - Orange County Business Journal
Beta Bionics Inc. stock prediction for this week2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Using Python tools to backtest Beta Bionics Inc. strategiesEntry Point & Step-by-Step Swing Trade Plans - newser.com
What analysts say about Beta Bionics Inc stockEx-Dividend Date Alerts & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
What Fibonacci levels say about Beta Bionics Inc. reboundWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
How to manage a losing position in Beta Bionics Inc.Weekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
How to forecast Beta Bionics Inc. trends using time seriesExit Point & Risk Adjusted Swing Trade Ideas - newser.com
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025 - GlobeNewswire
Relative strength of Beta Bionics Inc. in sector analysisTrend Reversal & High Conviction Trade Alerts - newser.com
How Beta Bionics Inc. stock reacts to bond yieldsRate Hike & Precise Swing Trade Entry Alerts - newser.com
Beta Bionics, Inc. (NASDAQ:BBNX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Beta Bionics Inc Stock Analysis and ForecastDouble Top/Bottom Patterns & Exceptional Capital Growth - earlytimes.in
Live market analysis of Beta Bionics Inc.Quarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Is this a good reentry point in Beta Bionics Inc.2025 Top Decliners & Free Risk Controlled Daily Trade Plans - newser.com
Will Beta Bionics Inc. stock deliver strong dividend growth2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Beta Bionics Inc. stock volume spike explainedInsider Selling & Weekly Top Gainers Trade List - newser.com
Goldman Sachs Upgrades Beta Bionics (BBNX) - Nasdaq
How institutional ownership impacts Beta Bionics Inc. stockMarket Volume Summary & High Conviction Buy Zone Picks - newser.com
Goldman Sachs Upgrades Beta Bionics to Buy From Neutral, Adjusts Price Target to $26 From $18 - MarketScreener
Goldman Sachs upgrades Beta Bionics stock to Buy on diabetes tech growth By Investing.com - Investing.com South Africa
Goldman Sachs upgrades Beta Bionics stock to Buy on diabetes tech growth - Investing.com
Top chart patterns to watch in Beta Bionics Inc.Weekly Trend Report & High Conviction Buy Zone Picks - newser.com
0.22%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):